Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | SVP, Fin & Princ Acct Officer | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,516 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Tax withholding · Disposed 937 · Balance 34,516 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2021 Filed Mar 16, 2021 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 102 | $68.10 | $6,946.20 |
DisclosureSEC source: 0001209191-21-020765 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,749 Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 62 | $68.10 | $4,222.20 |
DisclosureSEC source: 0001209191-21-020765 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,851 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-020765 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,913 Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,058 | $68.70 | $72,683.97 |
DisclosureSEC source: 0001209191-21-016893 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,586 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $68.69 to $68.75. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 807 | $51.68 | $41,708.75 |
DisclosureSEC source: 0001209191-20-046774 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,644 F1 · price: The price shown above represents the weighted average price of the shares sold. The sale price range was $51.68 to $51.69. Read SEC document |
| July 03, 2020 Filed Jul 7, 2020 22:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 507 | $48.72 | $24,701.04 |
DisclosureSEC source: 0000917520-20-000025 · primary_doc.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,451 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,404 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · derivative · entry 7 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,404 Underlying: Common Stock · 3,404 shares Expires 2028-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2020. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 99 | $43.39 | $4,295.61 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 6 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,958 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 96 | $43.39 | $4,165.44 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 5 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,057 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,153 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 102 | $43.39 | $4,425.78 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,471 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 42 | $43.39 | $1,822.38 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,573 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 193 | $43.39 | $8,374.27 |
DisclosureSEC source: 0001209191-20-019567 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,615 Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:57 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010225 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,808 F2 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:57 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010225 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,436 F1 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,179 | $63.35 | $74,693.42 |
DisclosureSEC source: 0001209191-19-043856 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,078 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 120 | $56.14 | $6,736.80 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 6 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,257 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 180 | $56.14 | $10,105.20 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 5 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,337 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,086 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · derivative · entry 7 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,086 Underlying: Common Stock · 2,086 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,557 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 187 | $55.91 | $10,455.17 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,091 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 101 | $55.91 | $5,646.91 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,278 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 88 | $55.91 | $4,920.08 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,379 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011136 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,467 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 654 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011136 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,137 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| October 01, 2018 Filed Oct 4, 2018 00:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 48 | $64.51 | $3,096.48 |
DisclosureSEC source: 0001209191-18-054156 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,483 Read SEC document |
| August 10, 2018 Filed Aug 10, 2018 20:49 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,000 | $62.42 | $62,417.30 |
DisclosureSEC source: 0001209191-18-046245 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,531 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 109 | $54.15 | $5,902.35 |
DisclosureSEC source: 0001209191-18-021804 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,531 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:39 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 109 | $54.15 | $5,902.35 |
DisclosureSEC source: 0001209191-18-021804 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,640 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 175 | $56.14 | $9,824.50 |
DisclosureSEC source: 0001209191-18-019848 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,749 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 117 | $56.14 | $6,568.38 |
DisclosureSEC source: 0001209191-18-019848 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,924 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 187 | $56.23 | $10,515.01 |
DisclosureSEC source: 0001209191-18-019848 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,041 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019848 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,228 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:46 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 636 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011389 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,107 F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:46 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 396 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011389 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,471 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 21:26 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 160 | $47.41 | $7,585.87 |
DisclosureSEC source: 0001209191-17-062051 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,075 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.